Biotech

All Articles

James Wilson leaving Penn to introduce two brand new biotechs

.After greater than three decades, gene therapy trendsetter James Wilson M.D., Ph.D., is actually le...

3 biotechs try to trump the summertime heat through shedding workers

.As biotechs seek to turn a fresh web page in August, at the very least 3 providers have lost person...

venBio lifts $528M for 5th life sciences VC fund

.Pro venture capital firm venBio has raised another half a billion dollars to invest in biotechs dea...

Otsuka pays for $800M for Jnana and its clinical-stage PKU medication

.Otsuka Drug has actually picked up Boston-based Jnana Therapies for $800 million so the Oriental bi...

FibroGen lays off 75% of US personnel as possession flunks 2 more tests

.FibroGen is substantially reorganizing its organization, giving up 75% of its U.S. team and also st...

Tracon relax weeks after injectable PD-L1 inhibitor fall short

.Tracon Pharmaceuticals has actually chosen to unwind operations weeks after an injectable invulnera...

Ideaya bags option on Biocytogen bispecific ADC in $400M bargain

.Ideaya Biosciences is wagering $400 million in biobucks that a bispecific antibody-drug conjugate (...

Takeda takes $140M loss on failed epilepsy medicine, touts FDA run

.Our company currently know that Takeda is actually hoping to discover a pathway to the FDA for epil...

VBI Vaccines files for insolvency, looks for resource purchase

.Immunology biotech VBI Vaccinations is actually veering dangerously close to the defining moment, a...

Celldex anti-cKIT antibody lower colonies in another period 2 research study

.It's not easy to muscle in on a room as affordable as immunology, but Celldex Therapeutics feels th...